Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 12 Oct 2025
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
816not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

32 likely financings · 13 Sep 2025 – 12 Oct 2025 · the feed below shows one weekClick a canton to filter the feedMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 6–12 Oct 2025

50 capital increases · 7 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 6–12 Oct 2025
CompanyStatusNominal share capital (CHF)
before → after
New shares, % of
post-step shares
Announced roundnot disclosed in the SHABSHAB publishedSource
CompPair Technologies SAVD · la société a pour but le développement, la fabrication et la commercialisation de produits, concepts, …SHAB publication HR02-1006454332Likely financingscore 0.85173’463.89 → 220’121.53New shares 21.2%21.2%—9 Oct 2025SHAB publication HR02-1006454332
Alentis Therapeutics AGBL · Die Gesellschaft bezweckt die Entwicklung und Kommerzialisierung von Therapeutika auf dem Gebiet der …SHAB publication HR02-1006452922Likely financingscore 0.865’603’850.23 → 8’298’899.29New shares 32.5%32.5%—8 Oct 2025SHAB publication HR02-1006452922
AI2C Technologies AGZG · Die Gesellschaft bezweckt die Entwicklung, Herstellung und Vermarktung von Technologien basierend auf …SHAB publication HR02-1006452721Likely financingscore 0.80102’000 → 142’695New shares 28.5%28.5%—8 Oct 2025SHAB publication HR02-1006452721
Ecorobotix SAVD · la Société a pour but le développement, la production et la commercialisation d'appareils électroniques dans …SHAB publication HR02-1006452077Likely financingscore 0.744’296’903 → 4’453’055New shares 3.1%3.1%—7 Oct 2025SHAB publication HR02-1006452077
SQ Innovation AGZG · Entwicklung, Herstellung und Vermarktung von Produkten, die im Medizinal- sowie im Medtech-Bereich verwendet …SHAB publication HR02-1006450211Likely financingscore 0.80421’220.15 → 523’360.26New shares 19.5%19.5%—6 Oct 2025SHAB publication HR02-1006450211
South Pole Holding AGZH · Zweck der Gesellschaft ist der Erwerb, die Verwaltung und die Veräusserung von Beteiligungen an Unternehmen …SHAB publication HR02-1006449868Likely financingscore 0.60248’921.50 → 497’673.70New shares 50.0%50.0%—6 Oct 2025SHAB publication HR02-1006449868
PXL Vision AGZH · Die Gesellschaft bezweckt die Entwicklung von Software- und Hardwarelösungen, deren Vertrieb sowie das …SHAB publication HR02-1006449843Likely financingscore 0.60195’148 → 212’897New shares 8.3%8.3%—6 Oct 2025SHAB publication HR02-1006449843

43 other capital increases published this week ▸